{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:54:24Z","timestamp":1790430864958,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA179701"],"award-info":[{"award-number":["CA179701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA180212"],"award-info":[{"award-number":["CA180212"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA118638"],"award-info":[{"award-number":["CA118638"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA169716"],"award-info":[{"award-number":["CA169716"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA179701"],"award-info":[{"award-number":["CA179701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA180212"],"award-info":[{"award-number":["CA180212"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA118638"],"award-info":[{"award-number":["CA118638"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA169716"],"award-info":[{"award-number":["CA169716"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA179701"],"award-info":[{"award-number":["CA179701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA180212"],"award-info":[{"award-number":["CA180212"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA118638"],"award-info":[{"award-number":["CA118638"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA169716"],"award-info":[{"award-number":["CA169716"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ovarian cancer (OvCa) is the leading cause of death from gynecological malignancies. Five-year survival rate of OvCa ranges from 30\u201392%, depending on the spread of disease at diagnosis. Role of chemokines is well appreciated in cancer, including OvCa. However, their precise role is understudied. Here, we show clinical and biological significance of CXCR6-CXCL16 and ADAM10 in OvCa. Expression of CXCR6 and N-terminal CXCL16 was significantly higher in serous carcinoma tissues compared to endometrioid. OvCa cells (SKOV-3 and OVCAR-3) also showed higher expression of CXCR6 than normal ovarian epithelial cells (IOSE-7576) while CXCL16 was higher in SKOV-3 than IOSE-7576. Furthermore, N-terminal CXCL16 was higher in conditioned media of OvCa cells than IOSE-7576. Compared to OVCAR-3, SKOV-3 cells, which had higher CXCL16, expressed significantly higher transcripts of ADAM10, a protease that cleaves CXCL16. OVCAR-3 cells showed higher CXCR6 specific migration whereas SKOV-3 cells showed more invasion. Difference in invasive potential of these cells was due to modulation of different MMPs after CXCL16 stimulation. Higher CXCR6 expression in serous papillary carcinoma tissues suggests its association with aggressive OvCa. Increased migration-invasion towards CXCL16 implies its role in metastatic spread. Therefore, CXCR6-CXCL16 axis could be used to differentiate between aggressive versus non-aggressive disease and as a target for better prognosis.<\/jats:p>","DOI":"10.1038\/s41598-019-38766-6","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T11:03:38Z","timestamp":1550747018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation"],"prefix":"10.1038","volume":"9","author":[{"given":"Hina","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James W.","family":"Lillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"38766_CR1","doi-asserted-by":"publisher","unstructured":"Bian, X. W. et al. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 61, 570\u2013578; discussion 578\u2013579, https:\/\/doi.org\/10.1227\/01.neu.0000290905.53685.a2 (2007).","DOI":"10.1227\/01.neu.0000290905.53685.a2"},{"key":"38766_CR2","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1172\/JCI62110","volume":"122","author":"HJ Chen","year":"2012","unstructured":"Chen, H. J. et al. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. The Journal of clinical investigation 122, 3184\u20133196, https:\/\/doi.org\/10.1172\/JCI62110 (2012).","journal-title":"The Journal of clinical investigation"},{"key":"38766_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbcan.2010.01.004","volume":"1806","author":"L Deng","year":"2010","unstructured":"Deng, L., Chen, N., Li, Y., Zheng, H. & Lei, Q. CXCR6\/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochimica et biophysica acta 1806, 42\u201349, https:\/\/doi.org\/10.1016\/j.bbcan.2010.01.004 (2010).","journal-title":"Biochimica et biophysica acta"},{"key":"38766_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2184.2011.00757.x","volume":"44","author":"CP El-Haibi","year":"2011","unstructured":"El-Haibi, C. P., Singh, R., Sharma, P. K., Singh, S. & Lillard, J. W. Jr. CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation. Cell proliferation 44, 311\u2013319, https:\/\/doi.org\/10.1111\/j.1365-2184.2011.00757.x (2011).","journal-title":"Cell proliferation"},{"key":"38766_CR5","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.18632\/oncotarget.2526","volume":"5","author":"P Gupta","year":"2014","unstructured":"Gupta, P. et al. CCR9\/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget 5, 10170\u201310179 (2014).","journal-title":"Oncotarget"},{"key":"38766_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3892\/ijo.2011.953","volume":"38","author":"C Johnson-Holiday","year":"2011","unstructured":"Johnson-Holiday, C. et al. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. International journal of oncology 38, 1279\u20131285, https:\/\/doi.org\/10.3892\/ijo.2011.953 (2011).","journal-title":"International journal of oncology"},{"key":"38766_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3892\/or.2011.1528","volume":"27","author":"J Liu","year":"2012","unstructured":"Liu, J., Zhang, L. & Wang, C. CCL21 modulates the migration of NSCL cancer by changing the concentration of intracellular Ca2+. Oncology reports 27, 481\u2013486, https:\/\/doi.org\/10.3892\/or.2011.1528 (2012).","journal-title":"Oncology reports"},{"key":"38766_CR8","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1365-2133.2011.10489.x","volume":"165","author":"BK Lo","year":"2011","unstructured":"Lo, B. K. et al. CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes. The British journal of dermatology 165, 1030\u20131036, https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10489.x (2011).","journal-title":"The British journal of dermatology"},{"key":"38766_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50\u201356, https:\/\/doi.org\/10.1038\/35065016 (2001).","journal-title":"Nature"},{"key":"38766_CR10","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/ijc.25219","volume":"127","author":"PK Sharma","year":"2010","unstructured":"Sharma, P. K. et al. CCR9 mediates PI3K\/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide. International journal of cancer. Journal international du cancer 127, 2020\u20132030, https:\/\/doi.org\/10.1002\/ijc.25219 (2010).","journal-title":"International journal of cancer. Journal international du cancer"},{"key":"38766_CR11","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1158\/0008-5472.can-03-3437","volume":"64","author":"SA Shulby","year":"2004","unstructured":"Shulby, S. A., Dolloff, N. G., Stearns, M. E., Meucci, O. & Fatatis, A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer research 64, 4693\u20134698, https:\/\/doi.org\/10.1158\/0008-5472.can-03-3437 (2004).","journal-title":"Cancer research"},{"key":"38766_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ijo.2011.1059","volume":"39","author":"R Singh","year":"2011","unstructured":"Singh, R., Stockard, C. R., Grizzle, W. E., Lillard, J. W. Jr. & Singh, S. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. International Journal of Oncology 39, 373\u2013381, https:\/\/doi.org\/10.3892\/ijo.2011.1059 (2011).","journal-title":"International Journal of Oncology"},{"key":"38766_CR13","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1002\/ijc.24574","volume":"125","author":"S Singh","year":"2009","unstructured":"Singh, S. et al. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. International Journal of Cancer 125, 2288\u20132295, https:\/\/doi.org\/10.1002\/ijc.24574 (2009).","journal-title":"International Journal of Cancer"},{"key":"38766_CR14","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s13277-013-0728-9","volume":"34","author":"W-n Wang","year":"2013","unstructured":"Wang, W.-n, Chen, Y., Zhang, Y.-d & Hu, T.-H. The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 34, 1865\u20131871, https:\/\/doi.org\/10.1007\/s13277-013-0728-9 (2013).","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"38766_CR15","doi-asserted-by":"publisher","first-page":"e33262","DOI":"10.1371\/journal.pone.0033262","volume":"7","author":"Y Xu","year":"2012","unstructured":"Xu, Y. et al. CCL21\/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells. PloS one 7, e33262, https:\/\/doi.org\/10.1371\/journal.pone.0033262 (2012).","journal-title":"PloS one"},{"key":"38766_CR16","doi-asserted-by":"publisher","first-page":"7343","DOI":"10.18632\/oncotarget.6944","volume":"7","author":"R Singh","year":"2016","unstructured":"Singh, R. et al. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and alphavbeta3 integrin clustering. Oncotarget 7, 7343\u20137353, https:\/\/doi.org\/10.18632\/oncotarget.6944 (2016).","journal-title":"Oncotarget"},{"key":"38766_CR17","doi-asserted-by":"publisher","first-page":"E2120","DOI":"10.1073\/pnas.1406655111","volume":"111","author":"P Chaturvedi","year":"2014","unstructured":"Chaturvedi, P., Gilkes, D. M., Takano, N. & Semenza, G. L. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment. Proceedings of the National Academy of Sciences of the United States of America 111, E2120\u20132129, https:\/\/doi.org\/10.1073\/pnas.1406655111 (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"38766_CR18","doi-asserted-by":"publisher","first-page":"9985","DOI":"10.18632\/oncotarget.3194","volume":"6","author":"H Mir","year":"2015","unstructured":"Mir, H., Singh, R., Kloecker, G. H., Lillard, J. W. Jr. & Singh, S. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Oncotarget 6, 9985\u20139998 (2015).","journal-title":"Oncotarget"},{"key":"38766_CR19","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1158\/0008-5472.can-06-3424","volume":"67","author":"S Hojo","year":"2007","unstructured":"Hojo, S. et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 67, 4725\u20134731, https:\/\/doi.org\/10.1158\/0008-5472.can-06-3424 (2007).","journal-title":"Cancer Res"},{"key":"38766_CR20","doi-asserted-by":"publisher","first-page":"675.e617","DOI":"10.1016\/j.urolonc.2017.08.019","volume":"35","author":"Y Chang","year":"2017","unstructured":"Chang, Y. et al. High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma. Urologic oncology 35, 675.e617\u2013675.e624, https:\/\/doi.org\/10.1016\/j.urolonc.2017.08.019 (2017).","journal-title":"Urologic oncology"},{"key":"38766_CR21","first-page":"297","volume":"33","author":"MN Wente","year":"2008","unstructured":"Wente, M. N. et al. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Int J Oncol 33, 297\u2013308 (2008).","journal-title":"Int J Oncol"},{"key":"38766_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/path.2053","volume":"210","author":"DL Ou","year":"2006","unstructured":"Ou, D. L., Chen, C. L., Lin, S. B., Hsu, C. H. & Lin, L. I. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. The Journal of pathology 210, 363\u2013373, https:\/\/doi.org\/10.1002\/path.2053 (2006).","journal-title":"The Journal of pathology"},{"key":"38766_CR23","doi-asserted-by":"publisher","first-page":"e15183","DOI":"10.1371\/journal.pone.0015183","volume":"5","author":"R Taghizadeh","year":"2010","unstructured":"Taghizadeh, R. et al. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. PloS one 5, e15183, https:\/\/doi.org\/10.1371\/journal.pone.0015183 (2010).","journal-title":"PloS one"},{"key":"38766_CR24","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.7150\/jca.24601","volume":"9","author":"T Yoneyama","year":"2018","unstructured":"Yoneyama, T. et al. ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker. Journal of Cancer 9, 2559\u20132570, https:\/\/doi.org\/10.7150\/jca.24601 (2018).","journal-title":"Journal of Cancer"},{"key":"38766_CR25","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3892\/ol.2016.5546","volume":"13","author":"B You","year":"2017","unstructured":"You, B. et al. Clinical significance of ADAM10 expression in laryngeal carcinoma. Oncology letters 13, 1353\u20131359, https:\/\/doi.org\/10.3892\/ol.2016.5546 (2017).","journal-title":"Oncology letters"},{"key":"38766_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jso.21781","volume":"103","author":"YY Wang","year":"2011","unstructured":"Wang, Y. Y. et al. ADAM 10 is associated with gastric cancer progression and prognosis of patients. Journal of surgical oncology 103, 116\u2013123, https:\/\/doi.org\/10.1002\/jso.21781 (2011).","journal-title":"Journal of surgical oncology"},{"key":"38766_CR27","doi-asserted-by":"publisher","first-page":"21968","DOI":"10.18632\/oncotarget.7880","volume":"7","author":"L Bruney","year":"2016","unstructured":"Bruney, L., Liu, Y., Grisoli, A., Ravosa, M. J. & Stack, M. S. Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells. Oncotarget 7, 21968\u201321981, https:\/\/doi.org\/10.18632\/oncotarget.7880 (2016).","journal-title":"Oncotarget"},{"key":"38766_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4331\/wjbc.v1.i7.209","volume":"1","author":"H Itamochi","year":"2010","unstructured":"Itamochi, H. Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action. World journal of biological chemistry 1, 209\u2013220, https:\/\/doi.org\/10.4331\/wjbc.v1.i7.209 (2010).","journal-title":"World journal of biological chemistry"},{"key":"38766_CR29","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/bjc.2014.55","volume":"110","author":"MJ Gooden","year":"2014","unstructured":"Gooden, M. J. et al. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity. British journal of cancer 110, 1535\u20131544, https:\/\/doi.org\/10.1038\/bjc.2014.55 (2014).","journal-title":"British journal of cancer"},{"key":"38766_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5732\/cjc.010.10490","volume":"30","author":"L Guo","year":"2011","unstructured":"Guo, L., Cui, Z. M., Zhang, J. & Huang, Y. Chemokine axes CXCL12\/CXCR4 and CXCL16\/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Chinese journal of cancer 30, 336\u2013343 (2011).","journal-title":"Chinese journal of cancer"},{"key":"38766_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4049\/jimmunol.171.4.1647","volume":"171","author":"T Shimaoka","year":"2003","unstructured":"Shimaoka, T. et al. Cutting edge: SR-PSOX\/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. Journal of immunology (Baltimore, Md.: 1950) 171, 1647\u20131651 (2003).","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"38766_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/art.21004","volume":"52","author":"R van der Voort","year":"2005","unstructured":"van der Voort, R. et al. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis and rheumatism 52, 1381\u20131391, https:\/\/doi.org\/10.1002\/art.21004 (2005).","journal-title":"Arthritis and rheumatism"},{"key":"38766_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4049\/jimmunol.176.1.43","volume":"176","author":"K Hase","year":"2006","unstructured":"Hase, K. et al. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT. Journal of immunology (Baltimore, Md.: 1950) 176, 43\u201351 (2006).","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"38766_CR34","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.4049\/jimmunol.172.6.3678","volume":"172","author":"PJ Gough","year":"2004","unstructured":"Gough, P. J. et al. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. Journal of immunology (Baltimore, Md.: 1950) 172, 3678\u20133685 (2004).","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"38766_CR35","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1074\/jbc.M311660200","volume":"279","author":"B Chandrasekar","year":"2004","unstructured":"Chandrasekar, B., Bysani, S. & Mummidi, S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. The Journal of biological chemistry 279, 3188\u20133196, https:\/\/doi.org\/10.1074\/jbc.M311660200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"38766_CR36","first-page":"149","volume":"8","author":"P Behrens","year":"2001","unstructured":"Behrens, P., Rothe, M., Florin, A., Wellmann, A. & Wernert, N. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. International journal of molecular medicine 8, 149\u2013154 (2001).","journal-title":"International journal of molecular medicine"},{"key":"38766_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1515\/bc.2003.137","volume":"384","author":"B Hantke","year":"2003","unstructured":"Hantke, B. et al. Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. Biological chemistry 384, 1247\u20131251, https:\/\/doi.org\/10.1515\/bc.2003.137 (2003).","journal-title":"Biological chemistry"},{"key":"38766_CR38","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.ejca.2003.08.011","volume":"39","author":"S Stadlmann","year":"2003","unstructured":"Stadlmann, S. et al. Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. European journal of cancer (Oxford, England: 1990) 39, 2499\u20132505 (2003).","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"38766_CR39","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1158\/0008-5472.can-09-4341","volume":"70","author":"A Agarwal","year":"2010","unstructured":"Agarwal, A. et al. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy. Cancer Res 70, 5880\u20135890, https:\/\/doi.org\/10.1158\/0008-5472.can-09-4341 (2010).","journal-title":"Cancer Res"},{"key":"38766_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ygyno.2010.10.032","volume":"120","author":"FQ Wang","year":"2011","unstructured":"Wang, F. Q., Fisher, J. & Fishman, D. A. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion. Gynecologic oncology 120, 247\u2013255, https:\/\/doi.org\/10.1016\/j.ygyno.2010.10.032 (2011).","journal-title":"Gynecologic oncology"},{"key":"38766_CR41","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1530\/rep-14-0546","volume":"150","author":"L Al-Alem","year":"2015","unstructured":"Al-Alem, L. & Curry, T. E. Jr. Ovarian cancer: involvement of the matrix metalloproteinases. Reproduction (Cambridge, England) 150, R55\u201364, https:\/\/doi.org\/10.1530\/rep-14-0546 (2015).","journal-title":"Reproduction (Cambridge, England)"},{"key":"38766_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature cell biology 2, 737\u2013744, https:\/\/doi.org\/10.1038\/35036374 (2000).","journal-title":"Nature cell biology"},{"key":"38766_CR43","first-page":"1048","volume":"58","author":"T Itoh","year":"1998","unstructured":"Itoh, T. et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58, 1048\u20131051 (1998).","journal-title":"Cancer Res"},{"key":"38766_CR44","first-page":"1101","volume":"11","author":"M Berube","year":"2005","unstructured":"Berube, M. et al. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Molecular vision 11, 1101\u20131111 (2005).","journal-title":"Molecular vision"},{"key":"38766_CR45","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/cncr.10355","volume":"94","author":"LA Di Nezza","year":"2002","unstructured":"Di Nezza, L. A. et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94, 1466\u20131475 (2002).","journal-title":"Cancer"},{"key":"38766_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ygyno.2003.09.012","volume":"92","author":"T Sato","year":"2004","unstructured":"Sato, T. et al. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecologic oncology 92, 47\u201356 (2004).","journal-title":"Gynecologic oncology"},{"key":"38766_CR47","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1023\/A:1006723011835","volume":"17","author":"B Davidson","year":"1999","unstructured":"Davidson, B. et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clinical & experimental metastasis 17, 799\u2013808 (1999).","journal-title":"Clinical & experimental metastasis"},{"key":"38766_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ygyno.2011.07.034","volume":"123","author":"CM Coticchia","year":"2011","unstructured":"Coticchia, C. M. et al. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecologic oncology 123, 295\u2013300, https:\/\/doi.org\/10.1016\/j.ygyno.2011.07.034 (2011).","journal-title":"Gynecologic oncology"},{"key":"38766_CR49","first-page":"145","volume":"74","author":"M Furuya","year":"1999","unstructured":"Furuya, M. Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors. Hokkaido igaku zasshi The Hokkaido journal of medical science 74, 145\u2013155 (1999).","journal-title":"Hokkaido igaku zasshi The Hokkaido journal of medical science"},{"key":"38766_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1095\/biolreprod.112.102327","volume":"89","author":"LF Al-Alem","year":"2013","unstructured":"Al-Alem, L. F., McCord, L. A., Southard, R. C., Kilgore, M. W. & Curry, T. E. Jr. Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10. Biology of reproduction 89, 73, https:\/\/doi.org\/10.1095\/biolreprod.112.102327 (2013).","journal-title":"Biology of reproduction"},{"key":"38766_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2011.05.008","volume":"309","author":"P Solar","year":"2011","unstructured":"Solar, P. & Sytkowski, A. J. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780. Cancer letters 309, 11\u201318, https:\/\/doi.org\/10.1016\/j.canlet.2011.05.008 (2011).","journal-title":"Cancer letters"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38766-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38766-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38766-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:25:59Z","timestamp":1671258359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38766-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["38766"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-38766-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2527"}}